Animal Euthanasia Market Size, Share & Trends Analysis Distribution, By Product (Pharmaceuticals (Barbiturates, Combination Drugs, and Non-barbiturate anesthetics), Inhalants, and Others), By Animal (Companion Animals, Livestock Animals, and Others), By Route of Administration (Injectable (Intravenous, Intramuscular, and Subcutaneous), Inhalants, and Others), By End Use (Veterinary Hospitals and Clinics, Animal Shelters & Rescue Centers, Research Laboratories & Universities, and Others), and Segment Forecasts, 2025-2034

Animal Euthanasia Market is valued at US$ 1.50 Bn in 2024 and it is expected to reach US$ 2.68 Bn by 2034, with a CAGR of 6.2% during the forecast period of 2025-2034.

Animal euthanasia involves the humane termination of an animal’s life to prevent unnecessary suffering or control disease spread. Guided by veterinary standards, it ensures rapid unconsciousness with minimal distress and safe carcass handling. The practice is applied across companion animal care, livestock management, wildlife control, and research settings. Growing pet ownership, rising veterinary care costs, and heightened awareness of ethical treatment are driving market expansion. Additionally, disease outbreaks in livestock and poultry increase the demand for humane depopulation methods. Advances in veterinary training, approved drugs, and equipment further support consistent, compassionate euthanasia practices worldwide.

The market is expanding because large-scale, disease-driven euthanasia events highlight the critical role of shelter medicine and emergency protocols, potentially increasing demand for veterinary euthanasia drugs, mobile euthanasia services, and disease-prevention measure. According to the ASPCA, an estimated 920,000 dogs and cats are euthanized annually in U.S. shelters, including about 390,000 dogs and 530,000 cats, mainly due to overpopulation and limited capacity. However, pentobarbital shortages and barbiturate supply shocks are some of the obstacles impeding the growth of the animal euthanasia sector. Over the course of the forecast period, opportunities for the animal euthanasia market will be created by specific growing emphasis on animal welfare programs, in-home end-of-life care, and humane alternatives.

Competitive Landscape

Some of the Key Players in Animal Euthanasia Market:

·       Zoetis Inc.

·       Boehringer Ingelheim GmbH

·       Merck & Co. Inc.

·       Elanco

·       Vetoquinol SA

·       Dechra Pharmaceuticals PLC

·       Virbac

·       Hikma Pharmaceuticals PLC

·       Akorn Animal Health, Inc.

·       Piramal Critical Care Inc.

·       Others

Market Segmentation:

The animal euthanasia market is segmented by product, animal, route of administration, and end use. By product, the market is segmented into pharmaceuticals,  inhalants, and others. pharmaceuticals is further classified into barbiturates, combination drugs, and non-barbiturate anesthetics. By animal, the market is segmented into companion animals, livestock animals, and others. By route of administration, the market is segmented into injectable, inhalants, and others. injectable are further classified into intravenous, intramuscular, and subcutaneous. By end use, the market is segmented into veterinary hospitals and clinics, animal shelters & rescue centers, research laboratories & universities, and others.

By Product, the Pharmaceuticals Segment is Expected to Drive the Animal Euthanasia Market

In 2024, the pharmaceuticals segment dominated the animal euthanasia market. This leadership is driven by the widespread preference for pharmaceutical agents in veterinary hospitals, clinics, and animal shelters due to their rapid onset of action, reliable outcomes, and minimal stress on animals. Pharmaceuticals have become the preferred choice for both companion and livestock animal euthanasia over mechanical or inhalant methods, supported by established regulatory approvals, broad availability, and extensive veterinary familiarity with these drugs.

Companion Animals Segment is Growing at the Highest Rate in the Animal Euthanasia Market

The companion animals segment dominated the animal euthanasia market, driven by rising pet ownership, growing pet humanization, and the increasing demand for compassionate end-of-life care. Pet owners are progressively seeking professional veterinary assistance both in-clinic and in-home to ensure a painless and dignified process for their dogs, cats, and other domestic animals. This segment’s commercial strength is further reinforced by deep emotional bonds between owners and pets, higher disposable incomes, and heightened awareness of ethical euthanasia practices, solidifying its leading position in the market.

Regionally, North America Led the Animal Euthanasia Market

In 2024, North America dominated the animal euthanasia market, with the United States leading regional growth. This dominance is attributed to advanced veterinary care infrastructure, rising pet ownership, and greater awareness of compassionate end-of-life care. The increasing popularity of in-home euthanasia services highlights the region’s focus on providing humane, accessible, and emotionally supportive options for pet owners.

The Asia-Pacific region is witnessing the fastest growth in the animal euthanasia market. Expanding pet ownership, improved veterinary services, and a growing understanding of humane end-of-life practices are driving this surge. Countries such as China and India are seeing particularly strong demand, fueled by the rapid increase in companion animals and the adoption of ethical pet care standards.

Animal Euthanasia Market Report Scope